Skip to content
Medistep Healthcare logo

Medistep Healthcare

MEDISTEP NSE
₹18.10 −1.40 (−7.18%)
P/E
11.31
View as Markdown
MCP
Close 4 Nov 2026 ₹18.10 −4.30 −19.2% 1Y
Start ₹22.40

Key Fundamentals

SMEPersonal ProductsFMCG

Price-based figures as of · TTM

ROCE
27.00%
Debt to Equity
0.14
EPS (TTM)
₹1.60
Book Value
₹26.62
Market Cap
—
P/E (TTM)
11.31
P/B
0.68
ROE
21.70%
Dividend Yield
0.00%
EBITDA
₹8.30 Cr
52W High
₹30.00
52W Low
₹16.50
Day Range
₹18.10 – ₹18.10
Volume
3,000

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Personal Care

Medistep Healthcare peer comparison
Godrej Consumer Products
₹849.0045.38₹86,648 Cr6.891.82%16.10%18.80%₹15,949 Cr₹1,914 Cr
Dabur India
₹395.0035.52₹69,681 Cr6.142.16%17.00%20.30%₹13,552 Cr₹1,947 Cr
Colgate Palmolive
₹1,660.7033.17₹45,422 Cr27.921.47%82.70%108.00%₹6,391 Cr₹1,362 Cr
Cupid
₹336.50329.90₹44,683 Cr100.451.48%27.60%33.90%₹484 Cr₹137 Cr
Gillette
₹7,527.0036.71₹23,745 Cr25.923.32%66.50%90.70%₹3,176 Cr₹668 Cr
P&G Hygiene and Health Care
₹6,959.0028.57₹22,555 Cr29.983.61%115.00%157.00%₹4,245 Cr₹790 Cr
Emami
₹381.3522.24₹16,773 Cr5.692.62%26.20%28.10%₹3,915 Cr₹749 Cr
Medistep Healthcare (this company)
₹18.1011.31₹28 Cr0.680.00%21.70%27.00%₹21 Cr₹2 Cr
Median 8 companies₹622.0034.35₹34,214 Cr16.411.99%26.90%31.00%₹4,080 Cr₹770 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

53 Average

Data confidence 95/100

Category scores

Quality
37
Weak
Returns, margins, earnings quality 22% weight
Valuation
46
Average
Cheap vs sector & own history 24% weight
Growth
88
Strong
Sales & profit trajectory 9% weight
Financial Health
74
Strong
Solvency, leverage, coverage 9% weight
Momentum
39
Weak
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.77 times its book value

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 203 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1252
OscillatorsNeutral252
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
40.63
Neutral
MACD (12,26,9)
−0.29
Bearish
SMA (50)
19.93
Bearish
SMA (200)
22.49
Bearish

As of

Growth Rate

From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
1Y+42.66%

Net profit

Net profit growth by window
1Y+44.44%

Operating cash flow

Operating cash flow growth by window
1YTurned negative

Operating margin· change in pp

Operating margin growth by window
1Y+0.36 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2025₹49.65 Cr
Mar 2026₹70.83 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2025₹4.14 Cr
Mar 2026₹5.98 Cr

Half-yearly Results

₹ Cr
MEDISTEP half-yearly results, ₹ crore
Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
21.25
28.4
35.07
35.76
Expenses
18.96
25.09
31.09
31.49
Operating Profit
2.29
3.31
3.98
4.27
OPM %
10.78%
11.65%
11.35%
11.94%
Other Income
0
0
0
0.02
Interest
0.02
0.01
0
0.25
Depreciation
0.02
0.02
0.01
0.01
PBT
2.25
3.28
3.97
4.03
Tax %
25.33%
25.3%
25.19%
25.06%
Net Profit
1.69
2.46
2.97
3.01
EPS (₹)
1.61
2.35
2.09
2.12

Profit & Loss

₹ Cr
MEDISTEP profit and loss, annual, ₹ crore
Particulars Mar 2024 9mMar 2025Mar 2026
Sales
31.6
49.65
70.83
Expenses
27.64
44.04
62.57
Operating Profit
3.96
5.61
8.26
OPM %
12.53%
11.3%
11.66%
Other Income
0.01
0
0.02
Interest
0.06
0.04
0.26
Depreciation
0.02
0.03
0.03
PBT
3.89
5.54
7.99
Tax %
25.19%
25.09%
25.16%
Net Profit
2.91
4.14
5.98
EPS (₹)
5.94
3.96
4.21
Div. Payout %
0%
0%
0%

Balance Sheet

₹ Cr
MEDISTEP balance sheet, annual, ₹ crore
Particulars Mar 2024Mar 2025Mar 2026
Equity Capital
4.9
10.47
14.21
Reserves
6.79
6.89
23.62
Borrowings
0.33
0.64
5.18
Other Liabilities
2.93
5
7.29
Total Liabilities
14.95
23
50.3
Fixed Assets
0.15
0.14
0.12
CWIP
0
0
0
Investments
0
0
0
Other Assets
14.8
22.86
50.18
Total Assets
14.95
23
50.3

Cash Flow

₹ Cr
MEDISTEP cash flow, annual, ₹ crore
Particulars Mar 2024Mar 2025Mar 2026
Operating
−7.11
0.02
−19.48
Investing
−0.15
0
−0.01
Financing
7.24
1.28
18.79
Net Cash Flow
−0.02
1.3
−0.7
Free Cash Flow
−7.26
0.02
−19.49
CFO/OP
−180
0
−224

Ratios

MEDISTEP financial ratios, annual
Particulars Mar 2024Mar 2025Mar 2026
Debtor Days
159
148
203
Inventory Days
12.41
9.23
36.52
Days Payable
18.81
20.55
21.57
Cash Conversion Cycle
152
137
218
Working Capital Days
134
117
191
ROCE %
—
37.18%
27.04%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medistep Healthcare insights

53 extracted metrics across FY24–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 68.96%
  • Public 27.22%
  • Others 3.82%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Medistep Healthcare

What does Medistep Healthcare Ltd do?
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.
Where is Medistep Healthcare Ltd (MEDISTEP) listed?
Medistep Healthcare Ltd trades as MEDISTEP on the NSE.
Which sector does Medistep Healthcare Ltd belong to?
Medistep Healthcare Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the PE ratio of Medistep Healthcare Ltd?
Medistep Healthcare Ltd trades at a PE ratio of 11.31 as of 4 Nov 2026, on earnings per share of ₹1.6, against a book value of ₹26.62 per share.
What is the 52-week high and low of Medistep Healthcare Ltd?
Over the last 52 weeks Medistep Healthcare Ltd has traded between ₹16.5 and ₹30 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Medistep Healthcare Ltd?
Medistep Healthcare Ltd reported a return on equity of 21.70%. Its debt-to-equity ratio is 0.14.

Company Information

Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.

Website medistephc.com
Listed 18 Aug 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDISTEP.md for Medistep Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Personal Care stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month